Pacira BioSciences CMO Jonathan Slonin sells 3,040 shares for $70,619.20

Reuters2026/08/18 21:21

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Pacira BioSciences Chief Medical Officer Jonathan Slonin sold 3,040 shares of common stock on Aug. 17, 2026.
Sale priced at USD 23.23 per share.
Directly owned stake stood at 216,383 shares following the transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pacira Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-057759), on August 18, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Pacira BioSciences CMO Jonathan Slonin sells 3,040 shares for $70,619.20

You may also like

Crypto prices